$586.50

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 2-3 weeks for production.
Sku CI02379_25_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Na-Fmoc-Nw-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine
Brand Name
Chem Impex
Product Number
02379
CAS
119831-72-0
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
3010429
IUPAC Name
(2S)-5-amino-(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonylaminomethylideneamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid
InChI Key
QTWZCODKTSUZJN-LJAQVGFWSA-N
SMILES
CC1=C(C(=C(C2=C1OC(CC2)(C)C)C)S(=O)(=O)NC(=NCCCC@@H(C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)N)C

Application

Na-Fmoc-Nw-(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-L-arginine is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a protective group in the synthesis of peptides, allowing for the selective modification of amino acids. Its stability under various conditions makes it a preferred choice for chemists.

Drug Development: In pharmaceutical research, it aids in the design of novel therapeutic agents, particularly those targeting specific biological pathways, enhancing drug efficacy and specificity.

Bioconjugation: The compound is instrumental in bioconjugation processes, where it helps link biomolecules to drugs or imaging agents, improving the delivery and effectiveness of treatments.

Research in Cancer Therapy: Its unique structure allows researchers to explore new avenues in cancer treatment, potentially leading to more effective and targeted therapies.

Protein Engineering: This chemical is used in modifying proteins to study their functions and interactions, providing insights that can lead to advancements in biotechnology and medicine.

References Data Source From Pubchem

The discovery, characterization and crystallographically determined binding mode of an FMOC-containing inhibitor of HIV-1 protease

Publication Name: Bioorganic & Medicinal Chemistry
Publication Date: 1997-07
DOI: 10.1016/s0968-0896(97)00078-3